GPR39 and adenocarcinoma: Figure 5 shows the results obtained for obestatin, GPR39, and Ki67 in the samples of human gastric adenocarcinomas, represented by a well-differentiated (WD) and a poorly differentiated (PD) adenocarcinoma (Figure 5A and 5B, respectively).